Version 2.78

Description

Barbiturates were first developed in 1864 by Adolf von Baeyer and were widely distributed by the Farbwerke Fr Bayer and Co in 1904. Barbiturates offered new treatment to patients with psychiatric and neurological disorders profoundly improving their prognoses. Barbiturates were also used to treat sleep disorders and were the first drugs to effectively treat epileptic seizures. Due to safety concerns related to drug dependence and overdose and new safer psychoactive medications barbiturate use sharply declined in the 1950s. PMID: 18568113 Butalbital, in conjunction with aspirin, acetaminophen and/or caffeine, is used to treat migraine and tension-type headaches. The use of butalbital can lead to intoxication, hangover, tolerance, dependence and toxicity. Patients on high doses of butalbital may experience withdrawal upon discontinuing the drug. PMID: 11903523 Source: Regenstrief LOINC

Basic Part Properties

Part Display Name
Butalbital
Part Type
Component (Describes the core component or analyte measured)
Created On
2000-05-04
Construct for LOINC Short Name
Butalbital

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP15046-3
ConceptMap translate
https://fhir.loinc.org/ConceptMap/$translate?system=http://loinc.org&code=LP15046-3

Language Variants Get Info

Tag Language Translation
zh-CN Chinese (China) 布他比妥
Synonyms: 山托扑他;异丁巴比妥
fr-CA French (Canada) Bultalbital
es-ES Spanish (Spain) Butalbital
it-IT Italian (Italy) Butalbitale
tr-TR Turkish (Turkey) Butalbital
ru-RU Russian (Russian Federation) Буталбитал
nl-NL Dutch (Netherlands) butalbital
fr-BE French (Belgium) Bultalbital